📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
15
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BLFS.
💹 Market Data
Market Cap$1.23B
Shares Outstanding48.86M
Float42.84M
Cash$81.00M
Debt$14.86M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 7.5% shares (2025Q4 vs prior)
187 institutional holders · 50.13M shares
#1
Casdin Capital, LLC
5.96M shares
#2
BlackRock, Inc.
5.91M shares
#3
T. Rowe Price Investment Management, Inc.
5.46M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest3.63M
Days to Cover9.2
% of Float8.5%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2023
xbrl
XBRL CONVERTIBLE
Dec 31, 2017
4
INSIDER TRANSACTION
Apr 10, 2026
4
INSIDER TRANSACTION
Apr 10, 2026
4
INSIDER TRANSACTION
Apr 10, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for BLFS
📊 BLFS FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 BLFS Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.